{"id":"cefadroxil-discontinued-early","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cefadroxil works by disrupting the cross-linking of peptidoglycan in bacterial cell walls, leading to cell wall instability and bacterial death. It is bactericidal and has broad-spectrum activity against gram-positive and some gram-negative bacteria. The drug is typically used for oral treatment of various bacterial infections.","oneSentence":"Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:29:50.915Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial skin and soft tissue infections"},{"name":"Urinary tract infections"},{"name":"Respiratory tract infections"},{"name":"Streptococcal pharyngitis"}]},"trialDetails":[{"nctId":"NCT01244698","phase":"PHASE4","title":"Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2010-11","conditions":"Bacterial Infection, Anti-infective Agents, Breast Implantation","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Clindamycin","Cleocin","Duricef","Ancef","Cefazolin"],"phase":"marketed","status":"active","brandName":"Cefadroxil discontinued early","genericName":"Cefadroxil discontinued early","companyName":"Stony Brook University","companyId":"stony-brook-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Used for Bacterial skin and soft tissue infections, Urinary tract infections, Respiratory tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}